{"id":"https://openalex.org/W2951806424","doi":"https://doi.org/10.1186/s13104-018-3526-z","title":"Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis","display_name":"Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis","publication_year":2018,"publication_date":"2018-06-28","ids":{"openalex":"https://openalex.org/W2951806424","doi":"https://doi.org/10.1186/s13104-018-3526-z","mag":"2951806424","pmid":"https://pubmed.ncbi.nlm.nih.gov/29954459","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6022709"},"language":"en","primary_location":{"id":"doi:10.1186/s13104-018-3526-z","doi":"https://doi.org/10.1186/s13104-018-3526-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13104-018-3526-z","pdf_url":"https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-018-3526-z","source":{"id":"https://openalex.org/S100014455","display_name":"BMC Research Notes","issn_l":"1756-0500","issn":["1756-0500"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Research Notes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-018-3526-z","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040571641","display_name":"Sheo Bux Singh","orcid":"https://orcid.org/0000-0002-6393-3583","observed_orcids":["https://orcid.org/0000-0002-6393-3583"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheo B. Singh","raw_affiliation_strings":["Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point PA, 19486, USA","Merck & Co., Inc., Infectious Diseases, West Point, USA","SBS Pharma Consulting LLC, Edison, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point PA, 19486, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck & Co., Inc., Infectious Diseases, West Point, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"SBS Pharma Consulting LLC, Edison, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055174241","display_name":"Joshua O. Odingo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Odingo","raw_affiliation_strings":["TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","TB Discovery Research, Infectious Disease Research Institute, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","institution_ids":["https://openalex.org/I1330732676"]},{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, Seattle, USA","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036960929","display_name":"Mai Ann Bailey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mai A. Bailey","raw_affiliation_strings":["TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","TB Discovery Research, Infectious Disease Research Institute, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","institution_ids":["https://openalex.org/I1330732676"]},{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, Seattle, USA","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020304295","display_name":"Bjorn Sunde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bjorn Sunde","raw_affiliation_strings":["TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","TB Discovery Research, Infectious Disease Research Institute, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","institution_ids":["https://openalex.org/I1330732676"]},{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, Seattle, USA","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070321412","display_name":"Aaron Korkegian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Korkegian","raw_affiliation_strings":["TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","TB Discovery Research, Infectious Disease Research Institute, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","institution_ids":["https://openalex.org/I1330732676"]},{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, Seattle, USA","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109102953","display_name":"Theresa O\u2019Malley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theresa O\u2019Malley","raw_affiliation_strings":["Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point PA, 19486, USA","TB Discovery Research, Infectious Disease Research Institute, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point PA, 19486, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, Seattle, USA","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089233697","display_name":"Yulia Ovechkina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yulia Ovechkina","raw_affiliation_strings":["TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","TB Discovery Research, Infectious Disease Research Institute, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","institution_ids":["https://openalex.org/I1330732676"]},{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, Seattle, USA","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048876954","display_name":"Thomas R. Ioerger","orcid":"https://orcid.org/0000-0001-8702-9102","observed_orcids":["https://orcid.org/0000-0001-8702-9102"]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas R. Ioerger","raw_affiliation_strings":["Texas A&M University, College Station, TX, USA","Texas A&M University, College Station, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas A&M University, College Station, TX, USA","institution_ids":["https://openalex.org/I91045830"]},{"raw_affiliation_string":"Texas A&M University, College Station, USA","institution_ids":["https://openalex.org/I91045830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103456216","display_name":"James C. Sacchettini","orcid":"https://orcid.org/0000-0001-5767-2367","observed_orcids":["https://orcid.org/0000-0001-5767-2367"]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James C. Sacchettini","raw_affiliation_strings":["Texas A&M University, College Station, TX, USA","Texas A&M University, College Station, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas A&M University, College Station, TX, USA","institution_ids":["https://openalex.org/I91045830"]},{"raw_affiliation_string":"Texas A&M University, College Station, USA","institution_ids":["https://openalex.org/I91045830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042149117","display_name":"Katherine Young","orcid":"https://orcid.org/0000-0002-1490-5455","observed_orcids":["https://orcid.org/0000-0002-1490-5455"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Young","raw_affiliation_strings":["Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point PA, 19486, USA","Merck & Co., Inc., Infectious Diseases, West Point, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point PA, 19486, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck & Co., Inc., Infectious Diseases, West Point, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004460784","display_name":"David B. Olsen","orcid":"https://orcid.org/0000-0001-5521-0206","observed_orcids":["https://orcid.org/0000-0001-5521-0206"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David B. Olsen","raw_affiliation_strings":["Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point PA, 19486, USA","Merck & Co., Inc., Infectious Diseases, West Point, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point PA, 19486, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck & Co., Inc., Infectious Diseases, West Point, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036429812","display_name":"Tanya Parish","orcid":"https://orcid.org/0000-0001-7507-0423","observed_orcids":["https://orcid.org/0000-0001-7507-0423"]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tanya Parish","raw_affiliation_strings":["TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","TB Discovery Research, Infectious Disease Research Institute, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, WA 98102, USA","institution_ids":["https://openalex.org/I1330732676"]},{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, Seattle, USA","institution_ids":["https://openalex.org/I1330732676"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5036429812"],"corresponding_institution_ids":["https://openalex.org/I1330732676"],"apc_list":{"value":1690,"currency":"USD","value_usd":1690},"apc_paid":{"value":1121,"currency":"EUR","value_usd":1208},"fwci":0.1167,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.37781469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"11","issue":"1","first_page":"416","last_page":"416"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.042899999767541885,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.025800000876188278,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclic-hexapeptide","display_name":"cyclic hexapeptide","score":0.9589999914169312},{"id":"https://openalex.org/keywords/natural-products","display_name":"natural products","score":0.8569999933242798},{"id":"https://openalex.org/keywords/antitubercular-activity","display_name":"antitubercular activity","score":0.9240000247955322},{"id":"https://openalex.org/keywords/mycobacterium-tuberculosis","display_name":"Mycobacterium tuberculosis","score":1.0},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9290000200271606},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.843999981880188},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.6439999938011169},{"id":"https://openalex.org/keywords/structural-analogs","display_name":"structural analogues","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.7642458081245422},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.6651833057403564},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.588397741317749},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.5387639999389648},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.4859217703342438},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.467693567276001},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3802657425403595},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3775254487991333},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.3275466859340668},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30130743980407715},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19770297408103943},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.12910789251327515},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10297638177871704},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08792620897293091},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0691119134426117}],"mesh":[{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1186/s13104-018-3526-z","doi":"https://doi.org/10.1186/s13104-018-3526-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13104-018-3526-z","pdf_url":"https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-018-3526-z","source":{"id":"https://openalex.org/S100014455","display_name":"BMC Research Notes","issn_l":"1756-0500","issn":["1756-0500"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Research Notes","raw_type":"journal-article"},{"id":"doi:10.1101/279307","doi":"https://doi.org/10.1101/279307","is_oa":true,"landing_page_url":"https://doi.org/10.1101/279307","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2018/03/10/279307.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmh:oai:europepmc.org:4988223","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6022709","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6022709","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6022709","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Res Notes","raw_type":"Text"},{"id":"pmid:29954459","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29954459","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC research notes","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:08262b84837a447c981e710ff45199e3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/08262b84837a447c981e710ff45199e3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Research Notes, Vol 11, Iss 1, Pp 1-5 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13104-018-3526-z","doi":"https://doi.org/10.1186/s13104-018-3526-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13104-018-3526-z","pdf_url":"https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-018-3526-z","source":{"id":"https://openalex.org/S100014455","display_name":"BMC Research Notes","issn_l":"1756-0500","issn":["1756-0500"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Research Notes","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4452083370","display_name":null,"funder_award_id":"OPP1024038","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"}],"funders":[{"id":"https://openalex.org/F4320306137","display_name":"Bill and Melinda Gates Foundation","ror":"https://ror.org/0456r8d26"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2951806424.pdf","grobid_xml":"https://content.openalex.org/works/W2951806424.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1579808882","https://openalex.org/W1588458487","https://openalex.org/W1978066089","https://openalex.org/W1986180649","https://openalex.org/W1993191671","https://openalex.org/W2007562408","https://openalex.org/W2009664996","https://openalex.org/W2095318368","https://openalex.org/W2124075951","https://openalex.org/W2132984145","https://openalex.org/W2160400589","https://openalex.org/W2168123849","https://openalex.org/W2540620445","https://openalex.org/W4252761341"],"related_works":["https://openalex.org/W2986748467","https://openalex.org/W4298138348","https://openalex.org/W2973156264","https://openalex.org/W2026349425","https://openalex.org/W4414262173","https://openalex.org/W2005585556","https://openalex.org/W2188330095","https://openalex.org/W1991357372","https://openalex.org/W4366742607","https://openalex.org/W4403700705"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Our":[1],"aim":[2],"was":[3,21,39],"to":[4,60,84],"identify":[5,85],"natural":[6,18],"products":[7],"with":[8,36,53],"anti-tubercular":[9,37],"activity.":[10],"RESULTS:":[11],"A":[12,31],"set":[13,45],"of":[14,33,46,79],"~":[15],"500":[16],"purified":[17],"product":[19],"compounds":[20,50],"screened":[22],"for":[23,88],"inhibition":[24],"against":[25],"the":[26,89],"human":[27],"pathogen":[28],"Mycobacterium":[29],"tuberculosis.":[30],"series":[32],"cyclic":[34],"hexapeptides":[35],"activity":[38,69,76],"identified.":[40],"Five":[41],"analogs":[42,65],"from":[43,58],"a":[44],"sixteen":[47],"closely":[48],"related":[49],"were":[51],"active,":[52],"minimum":[54],"inhibitory":[55],"concentrations":[56],"ranging":[57],"2.3":[59],"8.9":[61],"\u03bcM.":[62],"Eleven":[63],"structural":[64],"had":[66],"no":[67],"significant":[68],"(MIC":[70],">":[71],"20":[72],"\u03bcM)":[73],"demonstrating":[74],"structure":[75],"relationship.":[77],"Sequencing":[78],"resistant":[80],"mutant":[81],"isolates":[82],"failed":[83],"changes":[86],"accounting":[87],"resistance":[90],"phenotype.":[91]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-06-27T00:00:00"}